Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma

Brandon M. Huffman, Zhaohui Jin, Siddhartha Yadav, Shruti Patel, David M. Nagorney, Mark Truty, Robert R Mc Williams, Thorvardur R Halfdanarson, Amit Mahipal

Research output: Contribution to journalArticle

Abstract

Small bowel adenocarcinoma is a rare malignancy with variable survival depending on multiple factors. Increased age, increased tumor stage, and low lymphocyte-to-monocyte ratio before surgery are associated with poor overall survival. Patients with stage III disease showed improved survival when provided adjuvant chemotherapy.

Original languageEnglish (US)
JournalClinical colorectal cancer
DOIs
StatePublished - Jan 1 2019

Fingerprint

Adenocarcinoma
Survival
Adjuvant Chemotherapy
Monocytes
Neoplasms
Lymphocytes

Keywords

  • Adjuvant therapy
  • Chemotherapy
  • Lymphocyte-to-monocyte ratio
  • Prognosis
  • Small bowel cancer

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. / Huffman, Brandon M.; Jin, Zhaohui; Yadav, Siddhartha; Patel, Shruti; Nagorney, David M.; Truty, Mark; Mc Williams, Robert R; Halfdanarson, Thorvardur R; Mahipal, Amit.

In: Clinical colorectal cancer, 01.01.2019.

Research output: Contribution to journalArticle

Huffman, Brandon M. ; Jin, Zhaohui ; Yadav, Siddhartha ; Patel, Shruti ; Nagorney, David M. ; Truty, Mark ; Mc Williams, Robert R ; Halfdanarson, Thorvardur R ; Mahipal, Amit. / Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. In: Clinical colorectal cancer. 2019.
@article{c0571c9cde2744a898b07a8815af596a,
title = "Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma",
abstract = "Small bowel adenocarcinoma is a rare malignancy with variable survival depending on multiple factors. Increased age, increased tumor stage, and low lymphocyte-to-monocyte ratio before surgery are associated with poor overall survival. Patients with stage III disease showed improved survival when provided adjuvant chemotherapy.",
keywords = "Adjuvant therapy, Chemotherapy, Lymphocyte-to-monocyte ratio, Prognosis, Small bowel cancer",
author = "Huffman, {Brandon M.} and Zhaohui Jin and Siddhartha Yadav and Shruti Patel and Nagorney, {David M.} and Mark Truty and {Mc Williams}, {Robert R} and Halfdanarson, {Thorvardur R} and Amit Mahipal",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.clcc.2019.05.002",
language = "English (US)",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",

}

TY - JOUR

T1 - Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma

AU - Huffman, Brandon M.

AU - Jin, Zhaohui

AU - Yadav, Siddhartha

AU - Patel, Shruti

AU - Nagorney, David M.

AU - Truty, Mark

AU - Mc Williams, Robert R

AU - Halfdanarson, Thorvardur R

AU - Mahipal, Amit

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Small bowel adenocarcinoma is a rare malignancy with variable survival depending on multiple factors. Increased age, increased tumor stage, and low lymphocyte-to-monocyte ratio before surgery are associated with poor overall survival. Patients with stage III disease showed improved survival when provided adjuvant chemotherapy.

AB - Small bowel adenocarcinoma is a rare malignancy with variable survival depending on multiple factors. Increased age, increased tumor stage, and low lymphocyte-to-monocyte ratio before surgery are associated with poor overall survival. Patients with stage III disease showed improved survival when provided adjuvant chemotherapy.

KW - Adjuvant therapy

KW - Chemotherapy

KW - Lymphocyte-to-monocyte ratio

KW - Prognosis

KW - Small bowel cancer

UR - http://www.scopus.com/inward/record.url?scp=85066799709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066799709&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2019.05.002

DO - 10.1016/j.clcc.2019.05.002

M3 - Article

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

ER -